|
2010/03/31 |
DiaC - EPA And DHA May Improve Kidney Health In Type 1 Diabetes |
Lee C, Sharp S, Wexler D, et al. Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and diabetic nephropathy - cohort analysis of the Diabetes Control and Complications Trial (DCCT). Diabetes Care. 2010 Jul;33(7):1454-6
|
Objective: To investigate the association between dietary n-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFAs) and the degree and development of albuminuria in type 1 diabetes.
Methods: We analyzed longitudinal data from 1,436 participants in the Diabetes Control and Complications Trial. We defined average intake of eicosapentaenoic- and docosahexaenoic acid from diet histories. Urinary albumin excretion rates (UAER) were measured over 24 hours; incident albuminuria was considered the first occurrence of an UAER >40 mg/24 hr sustained for >/=1 year in normo-albuminuric individuals.
Results: In a mean follow-up of 6.5 years, we observed a lower mean UAER [difference 22.7 mg/24 hr (95% CI 1.6, 43.8)] in the top vs. bottom third of dietary n-3 LC-PUFAs, but found no association with incident albuminuria.
Conclusions: Dietary n-3 LC-PUFAs appear inversely associated with the degree, but not with the incidence of albuminuria in type 1 diabetes. These findings require further investigation in prospective studies.
|
Source:
http://www.ncbi.nlm.nih.gov/pubmed/20357378
|
|